Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| FDA decides to not approve diet drug Orexigen's Contrave at the present time. |
 |
 |
| NY Times: In a rare move, the agency told the drug maker, Orexigen Therapeutics, that to win approval it must first do a long-term study to demonstrate that the drug, called Contrave, does not raise the risk of heart attacks. |
